These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 11715635)
1. Comparison of the tissue affinity of glucocorticoids to human lung, nasal and skin tissue in vitro. Högger P Arzneimittelforschung; 2001 Oct; 51(10):825-31. PubMed ID: 11715635 [TBL] [Abstract][Full Text] [Related]
2. Binding of glucocorticoids to human nasal tissue in vitro. Esmailpour N; Högger P; Rohdewald P Int Arch Allergy Immunol; 2000 Jun; 122(2):151-4. PubMed ID: 10878494 [TBL] [Abstract][Full Text] [Related]
3. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. Baumann D; Bachert C; Högger P Clin Exp Allergy; 2009 Oct; 39(10):1540-50. PubMed ID: 19538495 [TBL] [Abstract][Full Text] [Related]
4. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Valotis A; Högger P Respir Res; 2007 Jul; 8(1):54. PubMed ID: 17650349 [TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104 [TBL] [Abstract][Full Text] [Related]
6. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Freiwald M; Valotis A; Kirschbaum A; McClellan M; Mürdter T; Fritz P; Friedel G; Thomas M; Högger P Respir Res; 2005 Feb; 6(1):21. PubMed ID: 15727687 [TBL] [Abstract][Full Text] [Related]
7. Binding of aflatoxin B1 metabolites in extrahepatic tissues in fetal and infant mice and in adult mice with depleted glutathione levels. Larsson P; Tjälve H Cancer Res; 1992 Mar; 52(5):1267-77. PubMed ID: 1737389 [TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of N7-(2-hydroxypropyl)guanine in tissues of F344 rats after inhalation exposure to propylene oxide. Ríos-Blanco MN; Ranasinghe A; Lee MS; Faller T; Filser JG; Swenberg JA Carcinogenesis; 2003 Jul; 24(7):1233-8. PubMed ID: 12807731 [TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of phenacetin in rat nasal mucosa: dose-dependent binding to the glands of Bowman. Brittebo EB Cancer Res; 1987 Mar; 47(5):1449-56. PubMed ID: 3815346 [TBL] [Abstract][Full Text] [Related]
10. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Smith CL; Kreutner W Arzneimittelforschung; 1998 Sep; 48(9):956-60. PubMed ID: 9793625 [TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195 [TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103 [TBL] [Abstract][Full Text] [Related]
13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
14. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge. Diaz-Sanchez D; Tsien A; Fleming J; Saxon A Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860 [TBL] [Abstract][Full Text] [Related]
15. Ethyl acrylate risk assessment with a hybrid computational fluid dynamics and physiologically based nasal dosimetry model. Sweeney LM; Andersen ME; Gargas ML Toxicol Sci; 2004 Jun; 79(2):394-403. PubMed ID: 15056811 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of intracellular, membrane, and plasma binding sites for corticosterone in house sparrows. Breuner CW; Orchinik M Gen Comp Endocrinol; 2009 Sep; 163(1-2):214-24. PubMed ID: 19236873 [TBL] [Abstract][Full Text] [Related]
17. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Schäcke H; Rehwinkel H; Asadullah K; Cato AC Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related]
19. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects. Au WL; Skinner MF; Benfeldt E; Verbeeck RK; Kanfer I Skin Pharmacol Physiol; 2012; 25(1):17-24. PubMed ID: 21860254 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. Bochner BS; Rutledge BK; Schleimer RP J Immunol; 1987 Oct; 139(7):2303-7. PubMed ID: 3498758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]